Overview
This imaging study aims to assess the feasibility, biodistribution, and dosimetry of the imaging agent in subjects with metastatic UC, HR+ and HER2- breast cancer, TNBC, or NSCLC.
Eligibility
Inclusion Criteria:
- Are at least 18 years old at the time of signing the informed consent form (ICF)
- Have biopsy proven metastatic UC, HR+ and HER2- breast cancer, TNBC, or NSCLC
Exclusion Criteria:
- For Women of Childbearing Potential: Are pregnant or breastfeeding
Note: Additional criteria may apply and will be assessed by the study site


